| Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances M Ghaferi, M Koohi Moftakhari Esfahani, A Raza, S Al Harthi, ... Journal of Drug Targeting 29 (2), 131-154, 2021 | 71 | 2021 |
| Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma H Ebrahimi Shahmabadi, F Movahedi, M Koohi Moftakhari Esfahani, ... Tumor Biology 35, 4799-4806, 2014 | 67 | 2014 |
| Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery of Repurposed Anthelmintics for Cancer Therapy M Koohi Moftakhari Esfahani, SE Alavi, PJ Cabot, N Islam, EL Izake Pharmaceutics 14 (8), 1579, 2022 | 34 | 2022 |
| Efficacy of Cisplatin-loaded poly butyl cyanoacrylate nanoparticles on the ovarian cancer: an in vitro study SK Bagherpour Doun, SE Alavi, M Koohi Moftakhari Esfahani, ... Tumor Biology 35, 7491-7497, 2014 | 34 | 2014 |
| Study of Toxicity Effect of Pegylated Nanoliposomal Artemisinin on Breast Cancer Cell Line N Dadgar, SE Alavi, MKM Esfahani, A Akbarzadeh Indian Journal of Clinical Biochemistry 28 (4), 410-412, 2013 | 31 | 2013 |
| Drug delivery of hydroxyurea to breast cancer using liposomes SE Alavi, MKM Esfahani, F Alavi, F Movahedi, A Akbarzadeh Indian Journal of Clinical Biochemistry 28, 299-302, 2013 | 31 | 2013 |
| Archaeosome: as new drug carrier for delivery of paclitaxel to breast cancer SE Alavi, H Mansouri, MKM Esfahani, F Movahedi, A Akbarzadeh, ... Indian Journal of Clinical Biochemistry 29, 150-153, 2014 | 30 | 2014 |
| PEG-grafted liposomes for enhanced antibacterial and antibiotic activities: An in vivo study SE Alavi, MKM Esfahani, A Raza, H Adelnia, HE Shahmabadi NanoImpact 25, 100384, 2022 | 28 | 2022 |
| PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells MKM Esfahani, SE Alavi, PJ Cabot, N Islam, EL Izake Pharmaceutics 13 (10), 1605, 2021 | 26 | 2021 |
| Polybutylcyanoacrylate nanoparticles and drugs of the platinum family: Last status DRA Fatemeh, H Ebrahimi Shahmabadi, A Abedi, SE Alavi, F Movahedi, ... Indian Journal of Clinical Biochemistry 29, 333-338, 2014 | 26 | 2014 |
| Pegylation of Nanoliposomal Paclitaxel Enhances its Efficacy in Breast Cancer MKM Esfahani, SE Alavi, A Akbarzadeh, S Ghassemi, Z Saffari, ... Tropical Journal of Pharmaceutical Research 13 (8), 1195-1198, 2014 | 25 | 2014 |
| Cytotoxicity of liposomal Paclitaxel in breast cancer cell line mcf-7 MKM Esfahani, SE Alavi, F Movahedi, F Alavi, A Akbarzadeh Indian Journal of Clinical Biochemistry 28, 358-360, 2013 | 25 | 2013 |
| Effects of nanoliposomal and pegylated nanoliposomal artemisinin in treatment of breast cancer N Dadgar, M Koohi Moftakhari Esfahani, S Torabi, SE Alavi, ... Indian journal of clinical biochemistry 29, 501-504, 2014 | 24 | 2014 |
| Effect of gold nanoparticles on properties of nanoliposomal hydroxyurea: an in vitro study J Shahabi, HE Shahmabadi, SE Alavi, F Movahedi, MKM Esfahani, ... Indian Journal of Clinical Biochemistry 29, 315-320, 2014 | 23 | 2014 |
| In vitro evaluation of the efficacy of liposomal and pegylated liposomal hydroxyurea SE Alavi, MKM Esfahani, S Ghassemi, A Akbarzadeh, G Hassanshahi Indian Journal of Clinical Biochemistry 29, 84-88, 2014 | 23 | 2014 |
| Drug Delivery of Cisplatin to Breast Cancer by Polybutylcyanoacrylate Nanoparticles M Koohi Moftakhari Esfahani, SE Alavi, S Shahbazian, ... Advances in Polymer Technology 37 (3), 674-678, 2018 | 20 | 2018 |
| Development of Thiabendazole-Loaded Mesoporous Silica Nanoparticles for Cancer Therapy MKM Esfahani, N Islam, PJ Cabot, EL Izake ACS Biomaterials Science & Engineering 8 (10), 4153-4162, 2021 | 19 | 2021 |
| Release modeling and comparison of nanoarchaeosomal, nanoliposomal and pegylated nanoliposomal carriers for paclitaxel F Movahedi, H Ebrahimi Shahmabadi, SE Alavi, ... Tumor Biology 35, 8665-8672, 2014 | 17 | 2014 |
| Carboplatin niosomal nanoplatform for potentiated chemotherapy SE Alavi, A Raza, MKM Esfahani, A Akbarzadeh, SH Abdollahi, ... Journal of Pharmaceutical Sciences 111 (11), 3029-3037, 2022 | 16 | 2022 |
| β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells M Koohi Moftakhari Esfahani, SE Alavi, PJ Cabot, N Islam, EL Izake Pharmaceutics 14 (4), 884, 2022 | 16 | 2022 |
Seyed Ebrahim AlaviGriffith Universitygriffithuni.edu.au üzerinde doğrulanmış e-posta adresine sahip
